Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells

International Journal of Oncology

Volumn 34, Issue 1, 2009, Pages 89-96

  Kanda, Shigeru ^a,b   Miyata, Yasuyoshi ^a   Kanetake, Hiroshi ^a   Smithgall, Thomas E ^c  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Akt1; c Fes; Human renal carcinoma cells; NF B; Proliferation; siRNA

Indexed keywords

CYCLIN D1; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; PROTEIN KINASE FES; SMALL INTERFERING RNA; SN 50; FES PROTEIN, HUMAN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY TUMOR; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ANIMALS; CARCINOMA, RENAL CELL; CELL NUCLEUS; CELL PROLIFERATION; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 60749099878     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000132     Document Type: Article

References (32)

1. Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S and Dunham N: The c-Fes family of protein-tyrosine kinases. Crit Rev Oncog 9: 43-62, 1998.
2. Greer P: Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol 3: 278-289, 2002.
3. Haigh J, McVeigh J and Greer P: The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-Golgi network. Cell Growth Differ 7: 931-944, 1996.
4. Sangrar W, Zirgnibl RA, Gao Y, Muller WJ, Jia Z and Greer PA: An identity crisis for fps/fes: oncogene or tumor suppressor? Cancer Res 65: 3518-3522, 2005.
5. Delfino FJ, Stevenson H and Smithgall TE: A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer. J Biol Chem 281: 8829-8835, 2006.
6. Rogers JA, Read RD, Li J, Peters KL and Smithgall TE: Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues. J Biol Chem 271: 17519-17525, 1996.
7. Kanda S, Lerner EC, Tsuda S, Shono T, Kanetake H and Smithgall TE: The non-receptor protein-tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells. J Biol Chem 275: 10105-10111, 2000.
8. Kanda S, Mochizuki Y, Miyata Y and Kanetake H: The role of c-Fes in vascular endothelial growth factor-A-mediated signaling by endothelial cells. Biochem Biophys Res Commun 306: 1056-1063, 2003.
9. Kanda S, Miyata Y, Kanetake H and Smithgall TE: Nonreceptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy. Int J Mol Med 20: 113-121, 2007.
10. Kanda S, Kanetake H and Miyata Y: Downregulation of Fes inhibits VEGF-A-induced chemotaxis and capillary-like morphogenesis by cultured endothelial cells. J Cell Mol Med 11: 495-501, 2007.
11. Greer P, Haigh J, Mbamalu G, Khoo W, Bernstein A and Pawson T: The Fps/ Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 14: 6755-6763, 1994.
12. Cheng H, Rogers JA, Dunham NA and Smithgall TE: Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains. Mol Cell Biol 19: 8335-8343, 1999.
13. Cheng HY, Schiavone AP and Smithgall TE: A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells. Mol Cell Biol 21: 6170-6180, 2001.
14. Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, Vogelstein B and Velculescu VE: Mutational analysis of the tyrosine kinase in colorectal cancers. Science 300: 949, 2003.
15. Hutson TE and Figlin RA: Renal cell cancer. Cancer J 13: 282-286, 2007.
16. Kanda S, Miyata Y and Kanetake H: Current status and perspective of antiangiogenic therapy for cancer: urinary cancer. Int J Clin Oncol 11: 90-107, 2006.
17. Motzer RJ and Bukowski RM: Targeted therapy for metastatic renal cell carcinoma. J Clin Oncol 24: 5601-5608, 2006.
18. Karthaus HF, Schalken JA, Feitz WF Debruyne FM, De Haan PT, Bloemers HP and van de Ven WJ: Expression of the human fes cellular oncogene in renal cell tumors. Urol Res 14: 123-127, 1986.
19. Nakamura T, Kanda S, Yamamoto K, Kohno T, Maeda K, Matsuyama T and Kanetake H: Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility through partly phosphoinositide 3-kinase. Oncogene 20: 7610-7623, 2001.
20. Kanda S, Kanetake H and Miyata Y: Elevated expression of ERK 2 in human tumor cells chronically treated with PD98059. Biochem Biophys Res Commun 345: 1481-1486, 2006.
21. Kanda S, Miyata Y, Mochizuki Y, Matsuyama T and Kanetake H: Angiopoietin 1 is mitogenic for cultured endothelial cells. Cancer Res 65: 6820-6827, 2005.
22. Kanda S, Miyata Y, Kanetake H and Smithgall TE: Fibroblast growth factor-2 induces the activation of Src through Fes, which regulates focal adhesion disassembly. Exp Cell Res 312: 3015-3022, 2006.
23. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB: NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-88, 1999.
24. Tagliafico E, Siena M, Zanocco-Marani T, Manfredini R, Tenedini E, Montanari M, Grande A and Ferrari S: Requirement of the coiled-coil domains of p92c-Fes for nuclear localization in myeloid cells upon induction of differentiation. Oncogene 22: 1712-1723, 2003.
25. Zirngibl R, Schulze D, Mirski SE, Cole SP and Greer PA: Subcellular localization analysis of the closely related Fps/Fes and Fer protein-tyrosine kinases suggests a distinct role for Fps/Fes in vesicular trafficking. Exp Cell Res 266: 87-94, 2003.
26. Carlson A, Yates KE, Slamon DJ and Gasson JC: Spatial and temporal changes in the subcellular localization of the nuclear protein tyrosine linase, c-Fes. DNA Cell Biol 24: 225-234, 2005.
27. Mercurio F and Manning AM: Multiple signals converging on NF-κB. Curr Biol 11: 226-232, 1999.
28. Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin AS Jr: NK-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799, 1999.
29. Lin YZ, Yao SY, Veach RA, Torgerson TR and Hawiger J: Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membranepermeable motif and nuclear localization sequence. J Biol Chem 270: 14255-14258, 1995.
30. Voisset E, Lopez S, Dubreuil P and De Sepulveda P: The tyrosine kinase FES is an essential effecter of KITD816V proliferation signal. Blood 110: 2593-2499, 2007.
31. Lionberger JM and Smithgall TE: The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Res 60: 1097-1103, 2000.
32. Putzke AP, Hikita ST, Clegg DO and Rothman JH: Esential kinase-independent role of a Fer-like non-receptor tyrosine kinase in Caenorhabditis elegans morphogenesis. Development 132: 3185-3195, 2005.